HIV-1 persistence in lymph node T follicular helper cells (TFH) is mitigated by functional virus-specific T cell responses during hyperacute-treated HIV-1 infection
Omolara O. Baiyegunhi(Africa Health Research Institute), Zaza M. Ndhlovu(Ragon Institute of MGH, MIT and Harvard), Bruce D. Walker(Howard Hughes Medical Institute), Johan Pansegrouw, Nasreen Ismail(University of KwaZulu-Natal), Thumbi Ndung’u(Africa Health Research Institute), Jaclyn K. Mann(University of KwaZulu-Natal), Funsho Ogunshola(Ragon Institute of MGH, MIT and Harvard), Anele Mbatha(University of KwaZulu-Natal), Trevor Khaba(University of KwaZulu-Natal), Krista L. Dong(Harvard University), Thandeka Nkosi(Africa Health Research Institute), Ismail Jajbhay, Thandekile Ngubane(University of KwaZulu-Natal), Caroline Chasara(Africa Health Research Institute)
Cited by 0
Related Papers
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|981
Cervicovaginal Bacteria Are a Major Modulator of Host Inflammatory Responses in the Female Genital Tract
|Immunity|2015|824
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing
|New England Journal of Medicine|2020|801